Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSavills Regulatory News (SVS)

Share Price Information for Savills (SVS)

Share Price is delayed by 15 minutes
Get Live Data
811.00    3.00 (0.37%)
Bid:
810.00
Ask:
812.00
Spread: 2.00 (0.247%)
Market Cap: £1.12b
SVS Live PriceLast checked at - London Stock Exchange

Intraday Savills Share Chart

Interim Management Statement

12 May 2014 11:02

RNS Number : 8360G
Savills PLC
12 May 2014
 



 

12 May 2014

 

SAVILLS PLC

("Savills" or "the Company")

 

AGM Statement and Interim Management Statement

 

Savills plc, the international real estate advisor, is today holding its Annual General Meeting (AGM) at 12 noon, 33 Margaret Street, London, W1G 0JD, and provides the following Interim Management Statement (IMS) for the period to 12 May 2014.

 

During the first four months of the year Savills has traded as anticipated with continued growth in the UK, and a robust performance in both Asia and Continental Europe. Our US business has an improved pipeline and Cordea Savills, the Group's investment management business, has traded in line with our expectations of revenue and profit growth.

 

In the UK commercial markets Savills has continued to maintain a significant share of the Prime Central London investment and leasing markets, although, as anticipated, the shortage of supply of investment stock has become increasingly apparent. Growth in investment volume outside London has continued from last year and development activity has further increased. We continue to expect regional recovery to be the primary driver of growth for our UK commercial business in 2014.

 

The UK Prime Residential market has continued to perform well with year on year increases in both volume and value. As anticipated, we have lately seen some cooling in the Prime and Super Prime Central London market. In contrast, there remains strong demand for property in the £1 million-£2 million price segments of the North, East and South West London regions. The regional UK residential market is continuing to recover with growing volumes and a significant increase in buyers registering with Savills.

 

In Asia Pacific, allowing for the material fall in trading volumes in Hong Kong in comparison with the same period last year, business has performed in line with expectations. Our Japanese business has continued to grow substantially as a result of the sustained strength of the Tokyo commercial investment market during the period. In mainland China, despite a slow down in transaction markets, revenue and earnings have grown in line with our expectations thanks to the growth of our Property Management business.

 

In Continental Europe, to date we have traded in line with our expectations, with strengthening performance in the transaction markets of Ireland, Spain, Germany and France.

 

Globally, our Consultancy business has experienced continued revenue growth with particular strengths in UK Development consultancy and UK/Continental European Valuation consultancy. The Property Management business has delivered a solid increase in revenue, particularly in the UK and in Asia where we continued to grow our market share in the core markets of Hong Kong and China.

 

Following a strong year of capital raising in 2013, Cordea Savills has grown revenue and profits in line with our expectations for the period to date, whilst continuing to experience significant capital inflows.

 

In the US, the existing Savills business has performed in line with expectations and our proposed acquisition of Studley Inc. was unanimously approved at the Studley Stockholder meeting held yesterday. Pending expiry of the Hart-Scott-Rodino Antitrust notification period, it is anticipated that the transaction will be completed on 30th May 2014.

 

 

For further information, contact:

 

Savills 020 7409 8934

Jeremy Helsby, Group Chief Executive

Simon Shaw, Group Chief Financial Officer

 

Tulchan Communications 020 7353 4200

Peter Hewer

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCEAESAFEFLEFF
Date   Source Headline
1st Oct 202511:00 amRNSTotal Voting Rights
29th Sep 202512:09 pmRNSDirector Declaration
25th Sep 20257:00 amRNSDirectorship Change
11th Sep 202512:38 pmRNSDirector/PDMR Shareholding
5th Sep 20252:00 pmRNSAdditional Listing
14th Aug 20257:00 amRNSHalf-year Report
12th Aug 20252:39 pmRNSDirector/PDMR Shareholding
1st Aug 20253:41 pmRNSHolding(s) in Company
21st Jul 20252:03 pmRNSBlock listing Interim Review
16th Jul 20251:44 pmRNSHolding(s) in Company
15th Jul 20254:20 pmRNSHolding(s) in Company
14th Jul 20251:14 pmRNSHolding(s) in Company
14th Jul 202510:18 amRNSDirector/PDMR Shareholding
1st Jul 20257:00 amRNSTotal Voting Rights
30th Jun 20255:20 pmRNSDirector/PDMR Shareholding
23rd Jun 20252:45 pmRNSHolding(s) in Company
20th Jun 20254:00 pmRNSAdditional Listing
12th Jun 20258:15 amRNSDirector/PDMR Shareholding
12th Jun 20258:10 amRNSDirector/PDMR Shareholding
10th Jun 20255:57 pmRNSDirector/PDMR Shareholding
4th Jun 202512:12 pmRNSHolding(s) in Company
2nd Jun 20253:05 pmRNSHolding(s) in Company
2nd Jun 20258:58 amRNSHolding(s) in Company
22nd May 20255:31 pmRNSHolding(s) in Company
15th May 20254:06 pmRNSHolding(s) in Company
14th May 20252:38 pmRNSResult of AGM
14th May 20257:00 amRNSAGM Statement
13th May 20254:01 pmRNSDirector/PDMR Shareholding
29th Apr 20257:00 amRNSSavills Announces Succession Plan
7th Apr 20254:18 pmRNSAnnual Report and AGM Notice
1st Apr 202511:00 amRNSTotal Voting Rights
24th Mar 20252:18 pmRNSHolding(s) in Company
21st Mar 20253:00 pmRNSAdditional Listing
20th Mar 20259:21 amRNSDirector/PDMR Shareholding
18th Mar 20252:27 pmRNSHolding(s) in Company
13th Mar 20257:00 amRNSFinal Results
12th Mar 202511:00 amRNSDirector/PDMR Shareholding
17th Feb 20254:43 pmRNSBlock listing Interim Review
12th Feb 202511:10 amRNSDirector/PDMR Shareholding
11th Feb 20252:32 pmRNSHolding(s) in Company
7th Feb 20253:51 pmRNSHolding(s) in Company
3rd Feb 202511:00 amRNSTotal Voting Rights
29th Jan 20252:28 pmRNSHolding(s) in Company
28th Jan 20253:47 pmRNSHolding(s) in Company
22nd Jan 202511:47 amRNSBlock listing Interim Review
16th Jan 20257:00 amRNSYear End Trading Update
13th Jan 20252:35 pmRNSDirector/PDMR Shareholding
2nd Jan 20253:00 pmRNSTotal Voting Rights
16th Dec 20244:03 pmRNSHolding(s) in Company
12th Dec 202411:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.